4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine

C95H119BBr4FN25O2 — CID 157485967

IUPAC4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine
SMILESBrc1ccnc(NCCN2CCCC2)c1.Brc1ccnc(NCCN2CCCC2)c1.CC1(C)OB(c2ccc3ncnc(N)c3c2)OC1(C)C.Fc1cc(Br)ccn1.NCCN1CCCC1.Nc1ncnc2ccc(-c3ccnc(CCCN4CCCC4)c3)cc12.Nc1ncnc2ccc(-c3ccnc(CCCN4CCCC4)c3)cc12.Nc1ncnc2ccc(Br)cc12
InChIInChI=1S/2C20H23N5.C14H18BN3O2.2C11H16BrN3.C8H6BrN3.C6H14N2.C5H3BrFN/c2*21-20-18-13-15(5-6-19(18)23-14-24-20)16-7-8-22-17(12-16)4-3-11-25-9-1-2-10-25;1-13(2)14(3,4)20-15(19-13)9-5-6-11-10(7-9)12(16)18-8-17-11;2*12-10-3-4-13-11(9-10)14-5-8-15-6-1-2-7-15;9-5-1-2-7-6(3-5)8(10)12-4-11-7;7-3-6-8-4-1-2-5-8;6-4-1-2-8-5(7)3-4/h2*5-8,12-14H,1-4,9-11H2,(H2,21,23,24);5-8H,1-4H3,(H2,16,17,18);2*3-4,9H,1-2,5-8H2,(H,13,14);1-4H,(H2,10,11,12);1-7H2;1-3H
InChIKeyBWSHGXYPYSRJKR-UHFFFAOYSA-N
MW1992.60 g/mol
LogP16.82
Rot. Bonds21

About 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine

4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine (PubChem CID 157485967) has the molecular formula C95H119BBr4FN25O2 and a molecular weight of 1992.60 g/mol. Its IUPAC name is 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine.

Molecular Properties

Compound Name4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine
PubChem CID157485967
Molecular FormulaC95H119BBr4FN25O2
Molecular Weight1992.60 g/mol
Exact Mass1987.68
IUPAC Name4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine
SMILESBrc1ccnc(NCCN2CCCC2)c1.Brc1ccnc(NCCN2CCCC2)c1.CC1(C)OB(c2ccc3ncnc(N)c3c2)OC1(C)C.Fc1cc(Br)ccn1.NCCN1CCCC1.Nc1ncnc2ccc(-c3ccnc(CCCN4CCCC4)c3)cc12.Nc1ncnc2ccc(-c3ccnc(CCCN4CCCC4)c3)cc12.Nc1ncnc2ccc(Br)cc12
InChIInChI=1S/2C20H23N5.C14H18BN3O2.2C11H16BrN3.C8H6BrN3.C6H14N2.C5H3BrFN/c2*21-20-18-13-15(5-6-19(18)23-14-24-20)16-7-8-22-17(12-16)4-3-11-25-9-1-2-10-25;1-13(2)14(3,4)20-15(19-13)9-5-6-11-10(7-9)12(16)18-8-17-11;2*12-10-3-4-13-11(9-10)14-5-8-15-6-1-2-7-15;9-5-1-2-7-6(3-5)8(10)12-4-11-7;7-3-6-8-4-1-2-5-8;6-4-1-2-8-5(7)3-4/h2*5-8,12-14H,1-4,9-11H2,(H2,21,23,24);5-8H,1-4H3,(H2,16,17,18);2*3-4,9H,1-2,5-8H2,(H,13,14);1-4H,(H2,10,11,12);1-7H2;1-3H
InChIKeyBWSHGXYPYSRJKR-UHFFFAOYSA-N
XLogP16.82
TPSA356.39 Ų
H-Bond Donors7
H-Bond Acceptors27
Rotatable Bonds21
Heavy Atoms128
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001992.60
LogP ≤ 516.82
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine?
The IUPAC name of 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine (CID 157485967) is 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine.
What is the SMILES notation for 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine?
The canonical SMILES for 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine is Brc1ccnc(NCCN2CCCC2)c1.Brc1ccnc(NCCN2CCCC2)c1.CC1(C)OB(c2ccc3ncnc(N)c3c2)OC1(C)C.Fc1cc(Br)ccn1.NCCN1CCCC1.Nc1ncnc2ccc(-c3ccnc(CCCN4CCCC4)c3)cc12.Nc1ncnc2ccc(-c3ccnc(CCCN4CCCC4)c3)cc12.Nc1ncnc2ccc(Br)cc12.
What is the InChIKey of 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine?
The InChIKey is BWSHGXYPYSRJKR-UHFFFAOYSA-N. The full InChI is InChI=1S/2C20H23N5.C14H18BN3O2.2C11H16BrN3.C8H6BrN3.C6H14N2.C5H3BrFN/c2*21-20-18-13-15(5-6-19(18)23-14-24-20)16-7-8-22-17(12-16)4-3-11-25-9-1-2-10-25;1-13(2)14(3,4)20-15(19-13)9-5-6-11-10(7-9)12(16)18-8-17-11;2*12-10-3-4-13-11(9-10)14-5-8-15-6-1-2-7-15;9-5-1-2-7-6(3-5)8(10)12-4-11-7;7-3-6-8-4-1-2-5-8;6-4-1-2-8-5(7)3-4/h2*5-8,12-14H,1-4,9-11H2,(H2,21,23,24);5-8H,1-4H3,(H2,16,17,18);2*3-4,9H,1-2,5-8H2,(H,13,14);1-4H,(H2,10,11,12);1-7H2;1-3H.
What are the key properties of 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine?
4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine has a molecular weight of 1992.60 g/mol, XLogP of 16.82, 21 rotatable bonds, 7 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 4-bromo-2-fluoropyridine;bis(4-bromo-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine);6-bromoquinazolin-4-amine;2-pyrrolidin-1-ylethanamine;bis(6-[2-(3-pyrrolidin-1-ylpropyl)-4-pyridinyl]quinazolin-4-amine);6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine is sourced from PubChem (CID 157485967), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).